AIM: To evaluate oral environmental changes in cannabis users. MATERIAL AND METHODS: The MEDLINE and Cochrane Central register of controlled trails (CENTRAL) were searched up to April 2007 to identify appropriate studies. RESULTS: Independent screening of 982 titles and abstracts (MEDLINE-Pubmed) and (Cochrane) papers resulted in seven eligible publications. CONCLUSION: Based on the limited data, it seems justified to conclude that with increasing prevalence of cannabis use, oral health care providers should be aware of cannabis-associated oral side effects, such as xerostemia, leukoedema and an increased prevalence and density of Candida albicans.
No takes yet. Share an insight, caveat, or question.
Versteeg et al. (2008) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: